Perihilar Cholangiocarcinoma

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) [NA]

  A clinical trial update notes that a study evaluating liver transplantation for non-resectable perihilar cholangiocarcinoma is currently rec…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT) [Phase 2]

  This is a Phase II prospective, single-arm trial evaluating a PD-L1 monoclonal antibody combined with chemoradiotherapy as a bridge to liver…

• CLINICAL_TRIALS research · 2026-02-09
  Clinical Trial Update: PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma [Phase 2]

  Phase 2 trial evaluating a PD-1 antibody plus GEMOX as postoperative adjuvant therapy for perihilar cholangiocarcinoma is currently recruiti…

• CLINICAL_TRIALS research · 2025-12-01
  Clinical Trial Update: Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma [Phase 2]

  Phase 2 clinical trial evaluating durvalumab in combination with intraductal radiofrequency ablation for unresectable extrahepatic cholangio…

• CLINICAL_TRIALS research · 2025-09-09
  Clinical Trial Update: Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

  This clinical trial POELH-III evaluates preoperative evaluation of lymph nodes in cholangiocarcinoma and is currently not yet recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-09-02
  Clinical Trial Update: Volume-Restricted Resection for Perihilar Cholangiocarcinoma

  This clinical trial update describes a study on volume-restricted resection for perihilar cholangiocarcinoma. It notes that enrollment has n…

• CLINICAL_TRIALS research · 2025-07-31
  Clinical Trial Update: Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma [NA]

  A clinical trial sponsored by Oslo University Hospital is evaluating liver transplantation for non-resectable perihilar cholangiocarcinoma (…

• CLINICAL_TRIALS research · 2025-05-23
  Clinical Trial Update: Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma

  A clinical trial is evaluating liver transplantation for unresectable perihilar cholangiocarcinoma (Klatskin tumor). The study is currently …

• CLINICAL_TRIALS research · 2025-04-11
  Clinical Trial Update: Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma [Phase 2, Phase 3]

  A Phase 2/3 clinical trial compares neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab versus upfront surgery in patient…

• CLINICAL_TRIALS research · 2024-12-06
  Clinical Trial Update: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study

  Prospective study evaluating robotically assisted surgery for perihilar cholangiocarcinoma is currently recruiting. Sponsored by Azienda Osp…